Regional university hospital
Besançon, 25000, France
NCT Number: NCT00536458
To compare localiezd radiotherapy to localized radiotherapy followed by 6 cycles of chemotherapy in the treatment of localiezd low grade lymphoma
Looking for future studies?
Notify Me18 year–79 year
All sexes
Interventional
Phase 3
Besançon, 25000, France
The standard treatment ol localized low grade lymphomas is Radiotherapy alone can offer long term remissions to some patients .
No study have clearly demonstrated the interest of chemotherapy. The purpose of the study is to determine wether prednisone administrated after first line local radiotherapy (30 GY) can pre in the treatment of localized low grade lymphomas of adult patients
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
mini chep+ radiotherapy
chemotherapy minichep 6 courses
Time frame: 5 years
Time frame: 5 years
Time frame: 6 months
Time frame: 6 months
French Innovative Leukemia Organisation
Other
Phase III Study of Treatment of Localized Lymphomas: Radiotherapy Versus Radio-Chemotherapie
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00168727
Hemic and Lymphatic Diseases, Immune System Diseases
Loma Linda, California, United States
View Trial DetailsNCT00546793
CLL, Chronic Disease
Savannah, Georgia, United States
View Trial DetailsNCT01181271
Chronic Disease, Chronic Lymphocytic Leukemia
Boston, Massachusetts, United States
View Trial DetailsNCT00143845
Blood Protein Disorders, Cardiovascular Diseases
Ann Arbor, Michigan, United States
View Trial Details